Upcoming events

Hereditary Cancer Syndromes in the Ob/Gyn Practice: A Panel Discussion

St. Regis Hotel, Gallery Ballroom, 125 Third Street, San Francisco, California 94103

May 16th, 5:00 PM - 6:45 PM

Featured Speakers
Debra Somers, MD, FACOG
Temple University Health System
Philadelphia, Pennsylvania

Jennifer Vasquez, MSN, WHNP-BC
Renaissance Women’s Group
Austin, Texas

Linda Bruzzone, Founder
Lynch Syndrome International
Vacaville, California

Target Audience
The educational design of this activity addresses the needs of physicians involved in the identification of patients with risk factors associated with hereditary cancer syndromes, and management of women identified with Lynch syndrome (HNPCC) or Hereditary Breast and Ovarian Cancer syndrome (HBOC).

Program
Progress has been made in the understanding and recognition of HBOC. Conversely, Lynch syndrome is much less understood and recognized, despite the fact that two cancers associated with the syndrome are gynecologic cancers. Debra Somers, MD, Jennifer Vasquez, MSN, WHNP, and a patient (a mutation carrier) will discuss their personal and/or practice experiences with hereditary cancers.

Following a reception and hors d’oeuvres, the panel will review the following:
• Hereditary cancers encountered in an Ob/Gyn setting
• Risk assessment for Lynch syndrome and HBOC
• Incorporation of hereditary testing into practice
• Management strategies for women identified as mutation carriers

A patient will share the story of her personal experience with genetic testing and the resultant decision-making process.

Purpose
At the end of this program, the physicians will have the knowledge, strategies, and tools to better understand hereditary cancer syndromes, evaluate risk, implement testing, understand hereditary testing and diagnosis from the patient perspective, and manage women with identified inherited risk of cancer.

Program Objectives
After completing this activity, the participant should be better able to:
1. Recognize the red flags for HBOC and Lynch syndrome
2. Explain what the results of hereditary testing mean in determining a patient’s risk for hereditary cancers
3. Identify the medical management strategies for the BRCA and MLH1, MSH2, and MSH6 mutation carriers
4. Describe the impact of genetic testing on patients

Symposium Agenda
5:00 p.m. – 5:30 p.m. Registration and Reception*
5:30 p.m. – 6:30 p.m. Hereditary Cancer Syndromes in the Ob/Gyn Practice: A Panel Discussion
6:30 p.m. – 6:45 p.m. Question & Answer Session

*Special dietary requests are accepted with advance notice.

Physician Continuing Medical Education
Accreditation Statement
Global is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
Global Education Group designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (physical, dietary, etc). Please contact Minerva Medical Communications prior to the live event at 904-388-3265.

This event is neither sponsored nor endorsed by ACOG.